HK Stock Market Move | GUSHENGTANG (02273) rose by more than 10% and plans to increase the maximum buyback amount by 300 million Hong Kong dollars. It is expected to distribute dividends of no less than 4.5 billion Hong Kong dollars per year from 2026 to 2028.

date
09:35 22/04/2026
avatar
GMT Eight
Kovidon Pharmaceuticals (02273) surged over 10%, as of the time of drafting, it rose by 9.06% to HKD 30.34, with a turnover of HKD 47.628 million.
GUSHENGTANG (02273) surged more than 10%, and at the time of writing, it was up by 9.06% to HK$30.34, with a trading volume of HK$47.62 million. In terms of news, GUSHENGTANG announced on April 21 that the board of directors had decided to further exercise the share repurchase authorization to repurchase shares in the open market, adding up to an additional HK$300 million. The board believes that the proposed share repurchase can enhance shareholder value and bring benefits to shareholders. Additionally, the proposed share repurchase will demonstrate the board's confidence in the long-term business prospects of the company, which will be in the best interests of the company and shareholders. On the same evening, GUSHENGTANG announced that in order to enhance shareholder returns, taking into consideration factors such as shareholder investment returns, company profit and cash flow, development needs, and financial stability, among others, and subject to applicable laws and regulations, the company expects to distribute cumulative cash dividends of not less than HK$450 million or 60% of the audited net profit attributable to shareholders for the fiscal years ending on December 31, 2026, 2027, and 2028, whichever is higher (dividend plan).